Background/Objectives: Several studies have raised the possibility of an association between alcohol consumption and the risk of developing restless legs syndrome (RLS). Moreover, an important percentage of patients under alcohol detoxification therapy develop RLS symptoms that fulfil the criteria for idiopathic RLS during alcohol withdrawal. We have aimed to establish the possible association between two common single nucleotide polymorphisms (SNPs) in the alcohol-dehydrogenase 1B (ADH1B) gene and the risk for RLS. Methods: We studied, using specific TaqMan assays, the genotype and allelic variant frequencies of ADH1B rs1229984 and ADH1B rs6413413 SNPs in 205 RLS patients and 505 gender-matched healthy controls. Results: The sum of the frequencies of rs1229984CT and rs1229984TT genotypes, as well as the frequency of the rs1229984T allelic variant, was significantly higher in RLS patients than in controls, both in the whole group and in females. The frequencies of genotypes and allelic variants of the rs6413413 SNP were similar between the two groups. RLS patients with the rs1229984CT genotype were younger, and those with the rs122984TT genotype older, at onset of RLS symptoms than those with the rs1229984CC genotype. None of the studied SNPs were related either with positivity of family history for RLS or with RLS severity. Conclusions: These results suggest an association between rs1229984 SNP and the risk for RLS.
INTRODUCTION
An important role of genetic factors in the etiology of restless legs syndrome (RLS) or Willis-Ekbom disease (WED) has been suggested by many studies, but the responsible gene(s) has (have) not definitively been identified (revised in Ref. 1). Genome Wide Association Studies (GWAS) show an association between several variants of the MEIS1 (chromosome 2p14p13), BTBD9 (chromosome 6p21), PTPRD (chromosome 9p24.1-p23), and MAP2K5/SKOR1 (chromosome 15q23) genes, and the variants rs3104767 at chromosome 16q12.1 and rs6747972 at chromosome 2p14 with the risk for RLS, whereas whole exome sequencing studies show an association with several variants in protocadherin alpha 3 (PCDHA3, chromosome 5q31) and with trafficking protein particle complex 6B (TRAPP6) genes in some families, and with the BTBD9 rs9357271 variant (revised in Ref. 1). Recently, our group described a significant though modest association between the rs2071746 single nucleotide polymorphism (SNP) in the heme-oxygenase 1 (HMOX1) 2 and the rs731236 (Taq1) SNP in the vitamin D3 receptor (VDR) gene, 3 and the risk of developing RLS in two case-control association studies.
Several reports, summarized in Table 1 , have addressed the issue of a possible relationship between alcohol intake and the risk or developing RLS. Most of these studies, which were performed with different designs, show a relationship between drinking status and RLS symptoms, with some exceptions; 8, 9, 12 although two of them show an increased risk of RLS, 4, 6 another four studies, 5, 8, 11, 13 including a large prospective cohort one, 13 show a decreased risk for RLS related with alcohol consumption. Aldrich et al. 4 described an increased risk for periodic limb movements and for RLS in subjects who consumed two or more alcoholic drinks per day compared with those who did not (details in Table 1 ). Finally, a recent report described RLS symptoms in 21.7% out of 180 subjects with primary alcohol use disorder during detoxification therapy in the first days following alcohol withdrawal.
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Statement of Significance
Despite the fact that considerable evidence suggests an important role of genetic factors in the etiology of restless legs syndrome, the responsible genes have not been clearly identified. In this case-control association study, based on the relationship between alcohol and restless legs syndrome, we analyzed two common polymorphisms in the alcohol-dehydrogenase 1B gene (which encodes an important enzyme involved in alcohol metabolism) in patients with restless legs syndrome and controls. Carriers of the rs1229984T (minor allele), which tend toward lower alcohol consumption, showed an increased risk for restless legs syndrome. This result is in agreement with several epidemiological studies, including one large prospective study, which show decreased risk for restless legs syndrome associated with some alcohol consumption.
It is thought that alcohol-dehydrogenase (ADH) enzymes, which participate in phase I of the metabolic pathways, 15 play an important role in the metabolism of ethanol, 16 retinoic acid, and dopamine. 17, 18 To the best of our knowledge, there are no reports on a possible relationship between ADH enzymes or ADH genes with RLS. ADH genes have been mapped to chromosome 4q23. One of them, designated as ADH1B (Gene ID 125; MIM 103720), 19 shows two relevant SNPs according to their expected effect on enzyme activity: rs1229984 (His48Arg) and rs6413413 (Thr60Ser). Although GWAS have not identified ADH1B SNPs among the possible susceptibility genes for RLS, it seems appropriate to investigate these SNPs because of the possible relationship between alcohol and RLS risk. For this reason, we genotyped rs1229984 and rs6413413 SNPs in the ADH1B gene in a cohort of Caucasian Spanish RLS patients and controls. Table 2 summarizes the demographic data from the 205 patients fulfilling diagnostic criteria for idiopathic RLS (iRLS) 20, 21 (all of them recruited by consultant neurologists subspecialized in Movement Disorders), and the 505 gender-matched healthy controls included in the current study. The patients diagnosed with iRLS included in the study were not exposed to drugs capable of aggravating or inducing RLS, had no previous history of systemic or neurological diseases (including anemia, rheumatoid arthritis, and renal failure), and underwent laboratory studies to exclude secondary causes of RLS (full details described elsewhere). 2, 3, [22] [23] [24] [25] [26] [27] Most of the subjects in this cohort had participated in other previous case-control association studies reported by our group; 2,3,22-27 RLS severity was assessed using the International RLS Study Group Rating Scale (IRLSSGRS). 28 The 505 controls, which were healthy (specifically, they had no systemic diseases, RLS, tremor, or other movement disorders, had no family history of RLS, and were not receiving any treatment related to these disorders; all of them underwent a medical examination), were Caucasian Spanish individuals matched by age and gender (although there was a minor difference in gender distribution- Table 2 -it did not reach statistical significance) and were recruited from the Clinica Universitaria de Navarra, Pamplona, Spain (240 subjects, healthy spouses of patients visiting this hospital, from different cities in Spain) and the Infanta Cristina University Hospital, Badajoz, Spain (265 subjects, students or staff from the University of Extremadura).
METHODS
Patients and Controls
Ethical Aspects
The study was approved by the Ethics Committees of Clinical Investigation of the University Hospital "Príncipe de Asturias" 
Genotyping
We studied using TaqMan probes two SNPs in ADH1B: ADH1B rs1229984 (C___2688467_20) and ADH1B rs6413413 (C__29127160_10, Life Technologies, Alcobendas, Madrid, Spain). These SNPs were selected on the basis of the expected effect on enzyme activity (both are nonsynonymous) and on their allele frequencies in Caucasian subjects. Both occur in the Spanish population. 29 Genotyping analysis was carried out using TaqMan probes in an Eppendorf realplex qPCR thermocycler. The amplification conditions were the following: after a denaturation time of 10 minutes at 96°C, 45 cycles of 92°C 15 seconds 60°C 90 seconds were carried out and fluorescence was measured at the end of each cycle and at endpoint. Determination of all the genotypes was done in triplicate, and the results were analyzed using gene identification software (RealPlex 2.0, Eppendorf) and analysis of the reference cycle number for each fluorescence curve, calculated using the CalQPlex algorithm (Eppendorf). Determination of the sample size was made from variant allele frequencies observed in control individuals with a genetic model analyzing the frequency for carriers of the disease gene with an RR value = 2 (p = .05). 32, 33 Statistical power, based on the actual allele frequencies for patients and controls in this study, for one-tailed and two-tailed associations, was, respectively, the following: ADH1B rs1229984 95.8% and 92.3%, and ADH1B rs6413413 53.5% and 41.7%.
Statistical Analysis
The negative predictive value was calculated as d/r2 (d = number of control individuals with risk factor absent, r2 = sum of patients and controls with risk factor absent). 34 Finally, the comparison of the mean age at onset among individuals with different genotypes for rs1229984 and rs6413413 was performed with ANOVA for independent samples.
RESULTS
The frequencies of the rs1229984 and rs6413413 genotypes and allelic variants were in Hardy-Weinberg's equilibrium, both in RLS patients and in control groups. The frequencies of the rs1229984CT genotype and the rs1229984T allele were significantly higher in RLS patients when compared with controls, both in the total group (Table 3 ) and in the female gender (Table 4) , and the differences remained as significant after multiple comparison analysis. Moreover, in the dominant model, comparisons between the frequencies of the genotypes rs1229984CT and TT vs CC were significantly higher in RLS patients, both in the total group (OR 2.13; 95%CI 1.41-3.22; p = .00029) and in females (OR 2.15; 95% CI 1.35-3.43; p = .0011). Frequencies of genotypes and allelic variants of rs6413413 SNP did not differ significantly between RLS patients and controls (Table 3) . Family history of RLS (positive vs negative) did not influence the frequencies of genotypes or allelic variants of both rs1229984 and rs6413413 SNPs (Table 5 ). RLS patients with the rs1229984CT genotype had a significantly younger age at onset of RLS symptoms, and those with rs122984TT were significantly older, than those with the rs1229984CC genotype, respectively ( Table 6 ). The severity of RLS symptoms, assessed by the IRLSSGRS, did not differ significantly among three genotypes of both rs1229984 and rs6413413 SNPs (Table 7) .
DISCUSSION
Although there are some controversies regarding the relationship between alcohol consumption and risk for RLS, most studies, including a recent prospective study, raise the possibility of an association between alcohol consumption and reduction of this risk. 5, 8, 11, 13 Moreover, the presence of RLS symptoms in an important percentage of patients under alcohol detoxification therapy after alcohol withdrawal 14 suggests a possible "protective" versus symptomatic effect of alcohol against RLS symptom development.
Alcohol has several effects on the dopaminergic system (with an important role in the pathophysiology of RLS), which include the following (revised in Ref . 35): (1) increase of dopamine release in the nucleus accumbens and in the amygdale through the promotion of synaptic terminal dopamine release or indirectly by affecting GABAergic neurons and/or opioid receptors; (2) increase of dopaminergic neuron discharges in the substantia nigra and in the ventral tegmental area; and (3) changes in the functioning of dopaminergic receptors, mainly reduction in striatal D2 density/D2 affinity ratio, and reduction of D2/D3 receptor affinity in the left temporal cortex, nucleus accumbens, and amygdale in subjects with alcohol dependence.
The main functional consequences of rs1229984 SNP include effects on alcohol metabolism and alcohol drinking behaviors, 36, 37 liver function, 36 risk for head and neck cancer, [36] [37] [38] [39] [40] esophageal cancer, 38 colorectal cancer, 41 hypertension, 42 and cardiovascular diseases. 43 With regard to neurological diseases, the frequency of the minor allele of this SNP has been reported to be lower in migraine patients than in controls but higher in those patients with migraine who reported triggering of migraine attacks by alcohol; 44 the rs1229984TT genotype has been found to be associated with increased risk for Alzheimer's disease, 45 and rs1229984 was not found to be associated with the risk for essential tremor 46 and Parkinson's disease. 47 In the present case-control association study, we found a significantly increased risk for RLS in carriers of the minor allele (T) of the rs1229984 SNP, which was unrelated with The values in each cell represent number (percentage; 95% confidence intervals). P = p nominal value; Pc = p corrected for multiple testing; NPV = negative predictive value.
the presence or absence of positive family history of RLS (the genotype distribution was similar in both subgroups), and a certain influence of this SNP onage at onset of the disease. Carriers of the rs1229984T allele, which encodes the most active form of the ADH1B enzyme, show a trend toward lower alcohol consumption, which has been attributed to the production of aversive effects related with a more rapid conversion of alcohol to acetaldehyde. 48 For this reason, we could hypothesize that the higher frequency of this allele found in RLS patients could be due to the lower consumption of alcohol found in several epidemiologic studies. 5, 8, 11, 13 Another possible hypothesis is that rs1229984T carriers were more predisposed to a worsening or eliciting effect of alcohol on RLS symptoms, leading them to avoid alcohol intake. However, because this and other studies with the participation of our cohort were designed to investigate candidate genes for RLS, specific information regarding the effect of alcohol on RLS symptoms was not requested of our patients.
We must acknowledge that the present study presents a number of limitations, such as the possibility of a selection bias related with the recruitment of the RLS patients in a hospital setting, the fact that the female:male ratio was higher than expected, the relatively low sample size, and the lack of previous similar studies (both of which imply the need for replication studies in other populations). In addition, we could not rule out the possibility that some control patients might develop RLS in the future, although their mean current age at recruitment was approximately 9 years older than the age at onset of RLS symptoms in the patient group. The minor difference in gender distribution (82.9% females among patients and 72.3% among control individuals) did not affect the results, because the allele frequencies in control individuals were virtually identical between men and women.
Taking in account these considerations, the results of the current study suggest a weak though significant association between ADH1B rs1229984 SNP and the risk for RLS. ADH1B rs6413413 A/A --- Table 7 -IRLSSGRS According to ADH1B Genotypes. 
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